Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)
Caicun Zhou(Shanghai Pulmonary Hospital), Caicun Zhou(Hunan Cancer Hospital), Lin Wu(Hunan Cancer Hospital), Yun Fan(Shandong Tumor Hospital), Zhehai Wang(Shandong Tumor Hospital), Lianke Liu(Harbin Medical University), Gongyan Chen(Harbin Medical University), Li Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Dingzhi Huang(Tianjin Medical University Cancer Institute and Hospital), Shundong Cang(Guangdong Medical College), Zhixiong Yang(Guangdong Medical College), Jianying Zhou(First Affiliated Hospital Zhejiang University), Chengzhi Zhou(Capital Medical University), Chengzhi Zhou(Sichuan Cancer Hospital), Baolan Li(Capital Medical University), Juan Li(Jilin University), Min Fan(Wenzhou Medical University), Jiuwei Cui(Jilin University), Yuping Li(Peking University), Hui Zhao(Anhui Medical University), Jian Fang(Central South University), Jianxin Xue(Sichuan University), Chengping Hu(Central South University), Ping Sun(Yuhuangding Hospital), Yingying Du(Anhui Medical University), Hui Zhou, Shuyan Wang, Wen Zhang
Cited by 308Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis